Familial adenomatous polyposis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Patients with adenomatous polyposis (those with 100 or more adenomas in the colorectum or those who have had 100 or more adenomas in total) who have visited a participating institution from January 2008 to March 31, 2027, or those with a pathogenic variant in the APC gene in the germline -Men and women aged 16 years or older Note: Includes patients who have visited the institution in the past. Postoperative patients are also included. Depending on the facility, the implementation may start as recently as January 2008, depending on the storage status of electronic medical records.
Exclusion criteria
Exclusion criteria: - Patients who refused to participate in this study -Patients who have visited the hospital less than three times, including second opinions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Life and Death | — |
Secondary
| Measure | Time frame |
|---|---|
| -Development of colorectal cancer -Development of non-colorectal cancer -Performance of colorectomy -Presence of desmoid - Colorectal polyp findings - Concomitant diseases - Adverse events associated with IDP, such as bleeding (grade, blood transfusion), perforation, emergency surgery, etc. - Birth status - Employment status | — |
Countries
Japan
Contacts
Kyoto Prefectural University of Medicine Department of Molecular-Targeting Cancer Prevention